/PRNewswire/ DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today reported financial results for the fourth.
DarioHealth Reports Fourth Quarter and Full Year 2020 Results and Operational Highlights
USA - English
Successfully secured multiple accounts in the B2B channel which are already enrolling members and generating revenue
Upright acquisition expands digital therapeutics offering to include musculoskeletal, attracting interest from existing and prospective B2B2C customers
Completed financing with elite healthcare funds provides capital to execute on growth initiatives with cash and cash equivalents of approximately $90 million at closing of the financing
Company to host conference call and webcast 8:30 am ET today.
News provided by
Share this article
Share this article
NEW YORK, March 9, 2021 /PRNewswire/ DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the fourth quarter and full year 2020 and provided a corporate and commercial update.
DarioHealth Reports Fourth Quarter and Full Year 2020 Results and Operational Highlights prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.